These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22213320)
1. Process development for the practical production of eldecalcitol by linear, convergent and biomimetic syntheses. Kubodera N; Hatakeyama S Anticancer Res; 2012 Jan; 32(1):303-9. PubMed ID: 22213320 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71]. Hatakeyama S; Yoshino M; Eto K; Takahashi K; Ishihara J; Ono Y; Saito H; Kubodera N J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):25-8. PubMed ID: 20304058 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment. Ono Y J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874 [TBL] [Abstract][Full Text] [Related]
4. The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism. Brown AJ; Ritter CS Calcif Tissue Int; 2011 Nov; 89(5):372-8. PubMed ID: 21912832 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of putative metabolites of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (ED-71). Ono Y; Watanabe H; Taira I; Takahashi K; Ishihara J; Hatakeyama S; Kubodera N Steroids; 2006 Jul; 71(7):529-40. PubMed ID: 16635499 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material. Kubodera N; Hatakeyama S Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150 [TBL] [Abstract][Full Text] [Related]
7. Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism. Ritter CS; Brown AJ J Cell Biochem; 2011 May; 112(5):1348-52. PubMed ID: 21337382 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71). Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172 [TBL] [Abstract][Full Text] [Related]
9. Enantioselective synthesis of A key A-ring intermediate for the preparation of 1α,25-dihydroxyvitamin D(3). Chen Y; Ju T Org Lett; 2011 Jan; 13(1):86-9. PubMed ID: 21133398 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of C-2 substituted vitamin D derivatives having ringed side chains and their biological evaluation, especially biological effect on bone by modification at the C-2 position. Saitoh H; Chida T; Takagi K; Horie K; Sawai Y; Nakamura Y; Harada Y; Takenouchi K; Kittaka A Org Biomol Chem; 2011 May; 9(10):3954-64. PubMed ID: 21472188 [TBL] [Abstract][Full Text] [Related]
11. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs. Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359 [TBL] [Abstract][Full Text] [Related]
13. Eldecalcitol for the treatment of osteoporosis. Noguchi Y; Kawate H; Nomura M; Takayanagi R Clin Interv Aging; 2013; 8():1313-21. PubMed ID: 24101867 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications. Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670 [TBL] [Abstract][Full Text] [Related]
15. New convergent synthesis of 1alpha,25-dihydroxyvitamin D3 and its analogues by Suzuki-Miyaura coupling between A-ring and C,D-ring parts. Hanazawa T; Koyama A; Nakata K; Okamoto S; Sato F J Org Chem; 2003 Dec; 68(25):9767-72. PubMed ID: 14656105 [TBL] [Abstract][Full Text] [Related]
16. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034 [TBL] [Abstract][Full Text] [Related]
17. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation. Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog. Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265 [TBL] [Abstract][Full Text] [Related]
19. Novel synthetic approach to 1alpha,25-dihydroxyvitamin D3 and analogues. Maestro M; Gómez-Reino C; Nicoletti D; Sigüeiro R; Fraga R; Ghini A; Torneiro M; Mouriño A J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):231-4. PubMed ID: 17254774 [TBL] [Abstract][Full Text] [Related]
20. Stereoselective convergent synthesis of 24-substituted metabolites and analogues of vitamin D. Cornella I; Suárez RM; Mouriño A; Sestelo JP; Sarandeses LA J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):19-23. PubMed ID: 15225740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]